{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "19626592", "DateCompleted": {"Year": "2010", "Month": "09", "Day": "22"}, "DateRevised": {"Year": "2010", "Month": "04", "Day": "27"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1002/med.20170"], "Journal": {"ISSN": "1098-1128", "JournalIssue": {"Volume": "30", "Issue": "4", "PubDate": {"Year": "2010", "Month": "Jul"}}, "Title": "Medicinal research reviews", "ISOAbbreviation": "Med Res Rev"}, "ArticleTitle": "Antitubercular potential of plants: a brief account of some important molecules.", "Pagination": {"StartPage": "603", "EndPage": "645", "MedlinePgn": "603-45"}, "Abstract": {"AbstractText": ["Mycobacterium tuberculosis is the most lethal pathogen causing tuberculosis in human. After the discovery of antitubercular drugs pyrazinamide, rifampicin, isoniazid, streptomycin, and ethambutol (PRISE), the disease was controlled for a limited period. However, over the course of their usage, the pathogen acquired resistance and evolved into multi-drug resistant, single-drug resistant, and extensive drug resistant forms. A good number of plant secondary metabolites are reported to have antitubercular activity comparable to the existing antitubercular drugs or sometimes even better in potency. A well-defined strategy is required to exploit these phytomolecules as antitubercular drugs. This review gives concise up-to-date information regarding the chemistry and pharmacology of plant-based leads and some insight into their structure-activity relationship."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Central Institute of Medicinal and Aromatic Plants, P.O. CIMAP, Kukrail Picnic Spot Road, Lucknow-226 015, India. arvindcimap@rediffmail.com"}], "Identifier": [], "LastName": "Negi", "ForeName": "Arvind S", "Initials": "AS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kumar", "ForeName": "Jonnala K", "Initials": "JK"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Luqman", "ForeName": "Suaib", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Saikia", "ForeName": "Dharmendra", "Initials": "D"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Khanuja", "ForeName": "Suman P S", "Initials": "SP"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Med Res Rev", "NlmUniqueID": "8103150", "ISSNLinking": "0198-6325"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antitubercular Agents"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "classification", "pharmacology", "therapeutic use"], "DescriptorName": "Antitubercular Agents"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Microbial Sensitivity Tests"}, {"QualifierName": ["drug effects"], "DescriptorName": "Mycobacterium tuberculosis"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants"}, {"QualifierName": ["diagnosis", "drug therapy", "epidemiology", "microbiology"], "DescriptorName": "Tuberculosis"}], "NumberOfReferences": "102"}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2009", "Month": "7", "Day": "24", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "7", "Day": "25", "Hour": "9", "Minute": "0"}, {"Year": "2010", "Month": "9", "Day": "24", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["19626592", "10.1002/med.20170"]}}], "PubmedBookArticle": []}